$284.99
Research Studies:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
FOXO4-DRI 10mg (Proxofim) is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
FOXO4-DRI 10mg (Proxofim) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 2460055-10-9 |
|---|---|
| Purity | ≥99% |
| Sequence | D-(Leu-Thr-Leu-Arg-Lys-Glu-Pro-Ala-Ser-Glu-Ile-Ala-Gln-Ser-Ile-Leu-Glu-Ala-Tyr-Ser-Gln-Asn-Gly-Trp-Ala-Asn-Arg-Arg-Ser-Gly-Gly-Lys-Arg-Pro-Pro-Pro-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly) |
| Molecular Formula | C₂₂₈H₃₈₈N₈₆O₆₄ |
| Molecular Weight | 358.06 g/mol |
| Applications | Senescence research, anti-aging studies, degenerative disease models |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy FOXO4-DRI online should evaluate FOXO4-DRI as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate FOXO4-DRI for controlled research procurement through Pure Lab Peptides, with attention to documentation quality, supplier language, analytical testing, and research-use-only boundaries.
Researchers can buy FOXO4-DRI online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase buy FOXO4-DRI online is addressed here as laboratory research procurement intent, not personal-use intent. In a research context, the search should lead qualified researchers, laboratory buyers, research institutions, and technical procurement teams toward documentation review rather than product-use claims. The appropriate evaluation questions are whether the material is clearly labeled for research use only, whether a batch-specific COA is available, whether purity and identity testing are documented, and whether the supplier avoids language that suggests therapeutic, diagnostic, veterinary, consumer, or personal-use positioning.
RUO terminology is most formally discussed in regulatory contexts for in vitro diagnostic products, where labeling distinguishes research materials from diagnostic products. While laboratory peptide procurement is not the same as IVD labeling, the principle is useful: intended-use language, labeling, and supplier claims matter when separating research materials from clinical or diagnostic positioning [1]. FDA guidance on RUO and IUO labeling also emphasizes that labeling and distribution practices should be consistent with the intended research-only status of a product [2].
FOXO4-DRI is a synthetic peptide research material discussed in published literature related to FOXO4-p53 interaction models and cellular senescence research. PubChem identifies FOXO4-DRI as a chemical compound record under CID 167312269 and lists the molecular formula C228H388N86O64 with the synonym FOXO4-DRI [3]. FOXO4 itself is the forkhead box O4 gene, and public gene and protein records describe FOXO4 as a forkhead transcription factor family member [4]. UniProt identifies the reviewed human FOXO4 protein entry as P98177 and annotates it as forkhead box protein O4 [5].
The “DRI” naming is commonly understood in the research literature as D-retro-inverso design. Retro-inverso peptide literature describes a strategy in which peptide sequence orientation and chirality are modified while researchers evaluate how those changes affect molecular behavior in specific models [6]. For FOXO4-DRI specifically, published work has examined the FOXO4-p53 axis and the use of a FOXO4-derived peptide in senescence-related experimental systems [7]. Later structural and biochemical publications further examined FOXO4, p53, and FOXO4-DRI interaction models, including solution NMR and intrinsically disordered region analysis [8] [9].
For procurement purposes, FOXO4-DRI should be evaluated as a FOXO4-DRI research material, not as a therapeutic product, diagnostic product, supplement, or consumer wellness item. The most relevant procurement attributes are identity documentation, FOXO4-DRI purity documentation, FOXO4-DRI identity testing, lot traceability, product form, storage documentation, and clear FOXO4-DRI research-use-only labeling.
Researchers search “buy FOXO4-DRI online” when they need to compare RUO product availability, supplier documentation, purity claims, identity data, and batch-specific records. The search is commercial, but in an RUO setting the commercial intent is procurement-focused: a laboratory buyer is evaluating whether the supplier provides enough information to support controlled research recordkeeping.
A qualified procurement review should not focus on expected outcomes. Instead, teams should ask whether the supplier provides a batch-specific FOXO4-DRI COA, whether the product name and lot number match across the label and documentation, whether the stated purity is supported by analytical evidence, whether the material is supplied in a documented form such as lyophilized powder, and whether the supplier avoids use-oriented or therapeutic claims. Researchers who buy FOXO4-DRI for controlled laboratory workflows should also review storage and handling documentation and retain procurement records according to internal laboratory procedures.
Before teams buy FOXO4-DRI online for laboratory research, they should review the same quality signals they would apply to other RUO peptide research materials: label language, COA access, analytical testing, lot traceability, and supplier transparency. HPLC is widely used in peptide analysis and purification, and mass spectrometry is commonly used to support identity and impurity characterization for synthetic peptides [10] [11] [12].
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the available batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
FOXO4-DRI supplier documentation should be evaluated as a set of connected records. A useful COA review begins with the compound name, lot number, test date, product form, and analytical method. The review should then compare the stated purity percentage with the method used to generate it and evaluate whether identity support is present through HPLC, LC-MS, mass spectrometry, or equivalent analytical documentation. ICH Q2(R2) describes validation principles for analytical procedures, and ICH Q14 describes science-based approaches for analytical procedure development [13] [14].
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. Laboratory buyers should also consider whether the testing organization and documentation practices support reliable records. ISO/IEC 17025:2017 is a general international standard for the competence of testing and calibration laboratories and is often used as a benchmark for confidence in testing operations [15]. ICH M10 also reinforces the broader principle that analytical methods should be suitable for their intended purpose when used to generate reliable data [16].
For lyophilized powder, storage and handling documentation should be reviewed as part of the procurement record. Stability guidance such as ICH Q1A(R2) emphasizes that storage conditions and stability information are part of systematic quality evaluation for materials under formal stability programs [17].
Published FOXO4-DRI literature should be read as scientific context, not as procurement proof and not as product-use guidance. The evidence landscape includes database records, peptide chemistry context, FOXO4 protein annotations, structural studies, in vitro models, preclinical models, and review-based senescence literature. A 2021 study evaluated FOXO4-DRI in in vitro expanded human chondrocyte research models [18]. A 2020 study evaluated FOXO4-DRI in aged mouse Leydig cell models, which should be understood as preclinical research context rather than product-use guidance [19]. A 2021 EBioMedicine article discussed development of a senolytic approach through disruption of the FOXO4-p53 complex [20].
More recent publications have examined FOXO4-DRI or related FOXO4-p53 peptide systems in additional cellular and oncology-adjacent model contexts, including keloid-derived senescent fibroblast models, peptide inhibitor work around FOXO4-p53 interactions, and endothelial senescence pathway models [21] [22] [23]. These studies do not make an RUO product interchangeable with a regulated medicine or clinical material. Oncology-adjacent or senescence-related literature must not be presented as therapeutic guidance or product-use claims.
General cellular senescence literature describes senescence as a complex cellular state studied across molecular, translational, and disease-adjacent research fields [24] [25] [26]. For procurement, the key point is limited: published literature can help researchers understand why a compound appears in a research category, but it does not replace batch-specific COA review, FOXO4-DRI identity testing, purity documentation, or supplier documentation.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular formula, chemical record, gene/protein context, and classification [3] | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | FOXO4-p53 interaction models and senescence-related research context [7] | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification using chromatography and mass spectrometry [11] | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations supported by documented storage information [17] | Laboratory documentation | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “FOXO4-DRI is discussed in published research related to FOXO4-p53 and senescence-related cellular models.” | Describes literature context without making a product claim | “FOXO4-DRI helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy FOXO4-DRI for results.” |
| “Pure Lab Peptides supplies FOXO4-DRI as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies FOXO4-DRI for therapy.” |
| “The phrase buy FOXO4-DRI online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy FOXO4-DRI online for personal use.” |
| “FOXO4-DRI supplier documentation should include purity, identity, and lot-level records.” | Keeps the discussion on procurement documentation | “Supplier claims can replace analytical documentation.” |
Pure Lab Peptides presents FOXO4-DRI 10mg as a research-use-only material for laboratory procurement. The product is positioned with an ≥99% purity claim, lyophilized powder form, and an available batch-specific COA. Researchers should review the Pure Lab Peptides FOXO4-DRI research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation.
For technical procurement teams, the strongest documentation workflow is to compare the product page, product label, batch-specific COA, lot number, product form, and storage information. The broader research peptide collection can help buyers compare documentation expectations across RUO materials. For general educational content, researchers may also review the Pure Lab Peptides blogs, and procurement teams can review shipping and returns information for operational planning.
Buy FOXO4-DRI online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published literature can explain why FOXO4-DRI appears in senescence-related or oncology-adjacent research discussions, but literature context is not the same as product-use guidance. RUO materials should be evaluated through compound identity, COA review, analytical testing, and laboratory documentation.
A stated purity percentage is only one quality signal. Researchers should review the FOXO4-DRI COA, analytical method, identity evidence, lot number, product form, and supplier documentation together. Purity data without identity confirmation is not a complete procurement record.
For RUO procurement, batch-specific documentation is central to traceability. A general specification sheet can be useful background, but the COA should match the material being procured through product name, lot number, analytical method, and reported results.
RUO labeling does not support clinical, diagnostic, veterinary, consumer, or personal-use positioning. It narrows the intended context to laboratory research. Supplier language should remain consistent with research procurement, analytical documentation, and controlled laboratory recordkeeping.
Supplier claims do not replace FOXO4-DRI supplier documentation. Laboratory buyers should prioritize batch-specific COA availability, method-based purity data, identity testing, lot traceability, storage information, and clear research-use-only language.
Researchers can buy FOXO4-DRI online for laboratory research from an RUO supplier that provides clear research-use-only labeling, batch-specific COA availability, purity documentation, identity information, storage guidance, and lot-level traceability. Pure Lab Peptides provides a FOXO4-DRI 10mg product page for researchers reviewing procurement documentation.
Before buying FOXO4-DRI online, researchers should check RUO labeling, the batch-specific COA, analytical method, purity data, identity support, product form, storage documentation, and lot number consistency. The supplier should also avoid therapeutic, diagnostic, veterinary, consumer, or personal-use positioning.
A FOXO4-DRI COA matters because it connects a specific lot to documented analytical results. Researchers should review compound name, lot number, test date, purity percentage, method, identity information, and any chromatogram or mass data supplied with the batch-specific documentation.
FOXO4-DRI discussed here is not intended for human or animal consumption. This article addresses FOXO4-DRI research-use-only procurement, documentation review, supplier evaluation, and laboratory recordkeeping. It does not provide personal-use guidance, medical advice, clinical instructions, or veterinary guidance.
Research use only means FOXO4-DRI is positioned as a laboratory research material for controlled research settings. For procurement, researchers should evaluate the label, product page, COA, purity documentation, identity testing, lot traceability, and storage information rather than expected outcomes or product-use claims.
Published FOXO4-DRI literature should be interpreted as scientific context, not as use guidance for RUO materials. Papers discussing FOXO4-p53 interactions, cellular models, structural work, or preclinical systems do not replace batch-specific COA review, analytical documentation, or supplier transparency.
Qualified researchers evaluating FOXO4-DRI should review product labeling, COA status, identity documentation, storage information, and supplier transparency before selecting any research-use-only material. Review the FOXO4-DRI product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.